Mobile

A Clinical trial to evaluate safety, and effectiveness of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) Estudio para evaluar la seguridad y la efi...

Update Il y a 4 ans
Reference: NCT03053063

A Clinical trial to evaluate safety, and effectiveness of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) Estudio para evaluar la seguridad y la eficacia de selonsertib en pacientes con cirrosis compensada debida a esteatohepatitis no alcohólica (EHNA)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is: To evaluate whether SEL can cause fibrosis regression and reduce associated complications in subjects with cirrhosis due to NASH. Objetivo principal: Evaluar si SEL puede causar regresión de la fibrosis y reducir las complicaciones asociadas en pacientes con cirrosis debida a EHNA.

Inclusion criteria

  • Nonalcoholic steatohepatitis (NASH),Esteatohepatitis no alcohólica (EHNA)

Links